Guzman y Gomez Exits US Market Amid Stiff Competition and Operational Challenges Summer Electric Bills Surge as Record Heat and Higher Rates Drive Up Cooling Costs ASEANBAC and AVPN Launch Regional Platform to Boost Corporate Social Investment Across Southeast Asia Pokmon Card Boom Nostalgia Speculation and Celebrity Collectors Fuel Surge in Trading Card Values Inflation Reacceleration Extends Beyond Iran and Oil Sectors Where Prices Are Rising Fast Canadian Horticulture Sector Navigates Tariff Challenges Through Local Sourcing Push CCB Q1 2026 Earnings EPS Misses Estimates Stock Declines COOK Q1 2026 Earnings Surprise Profit Beat Sends Mixed Signals as Revenue Details Remain Unclear LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management Red Violet RDVT Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Blue Gold Limited Warrant BGLWW Jumps 8 as Speculative Interest Intensifies Charlton Aria Acquisition Rights CHARR Plunge on Heavy Selling Rights May Approach Expiration Professional Diversity Network IPDN Gains 2 as Stock Nears Key Resistance Level Electromed Inc ELMD Holds Steady Near Resistance as Market Weighs Momentum Organon OGN Edges Higher as Price Action Stays Within Tight Range Amazons Unrivaled Dominance Why Western Retailers Struggle to Compete Oracle ORCL Gains Wedbush Price Target Hike as Analysts Point to Overlooked Demand Visibility AVX Q1 2026 Earnings Narrowing Loss in Core Operations Amid Quiet Quarter SBUX Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Challenges Stock Slips XOMA Q1 2026 Earnings Royalty Revenue Shortfall Pushes EPS Below Estimates Wes Streeting Proposes Capital Gains Tax Overhaul in Labour Leadership Bid Tech Billionaires Sway Trump to Abandon AI Executive Order Amidst Regulatory Divisions NetScout Systems NTCT Q1 2026 Earnings EPS Surpasses Estimates Amid Margin Discipline Esperion Therapeutics ESPR Holds Steady Amid Key Support and Resistance Levels